Klin Onkol. 2021 Fall;34(6):455-462. doi: 10.48095/ccko2021455.
The time factor plays a key role in radiotherapy. The radiotherapy overall treatment time is one of the most important predictive factors in the treatment effectiveness and is associated with better local control and impact on the overall survival. The length of the time from the dia-gnosis to radical radiotherapy or from surgery to adjuvant radiotherapy or the use of alternative fractionation schemes shortening the total treatment time also play an important role. The prevention of prolongation of the radiation series remains a fundamental and well feasible way of applying the time factor in radiotherapy.
Interruption of radiotherapy usually occurs for technical reasons, due to factors at the patients side or for personnel reasons of the department. Standard procedures for the compensation for treatment breaks are part of the treatment protocols at radiotherapy departments. Possible risks of the discontinuation of radiotherapy are considered on the basis of the type and extent of the disease, the treatment intent and the condition of the patient, and the need of compensation for a break in the treatment is set. Patients are classified into three categories according to the above mentioned parameters. Compensation for the pause in radiotherapy is performed by calculating the equivalent dose in 2 Gy per fraction (EQD2); the preferred method of compensation is the one which enables observation of the planned total time of radiotherapy without extension. The benefit of local tumor control and the risk of increased acute or especially late toxicity should always be considered. In the current epidemiological situation, radiotherapy is often discontinued for COVID-19, and due to longer breaks in the treatment, it is necessary to combine multiple compensation methods in one patient.
时间因素在放射治疗中起着关键作用。放射治疗的总治疗时间是治疗效果的最重要预测因素之一,与更好的局部控制和对总生存的影响相关。从诊断到根治性放疗的时间,或从手术到辅助放疗的时间,或使用替代分割方案缩短总治疗时间的长短也起着重要作用。预防放射治疗系列的延长仍然是在放射治疗中应用时间因素的基本且可行的方法。
放射治疗的中断通常由于技术原因、患者方面的因素或部门人员的原因而发生。放射治疗部门的治疗方案中包含了治疗中断补偿的标准程序。根据疾病的类型和程度、治疗意图和患者的状况,以及对治疗中断补偿的需要,考虑停止放射治疗的可能风险。根据上述参数,患者被分为三类。通过计算每 2 Gy 分数的等效剂量(EQD2)来补偿放射治疗的暂停;首选的补偿方法是能够观察到计划的总放射治疗时间而不延长的方法。应始终考虑局部肿瘤控制的益处和增加急性或特别是晚期毒性的风险。在当前的流行病学情况下,放射治疗经常因 COVID-19 而中断,由于治疗中断时间较长,需要在一位患者中结合多种补偿方法。